Ecallantide is a novel treatment for attacks of hereditary angioedema due to C1 inhibitor deficiency

References

• KaplanAPGreavesMWAngioedemaJ Am Acad Dermatol2005533373388 quiz38939216112343
   PubMed Web of Science ®Google Scholar
• BasMAdamsVSuvoravaTNiehuesTHoffmannTKKojdaGNonallergic angioedema: role of bradykininAllergy200762884285617620062
   PubMed Web of Science ®Google Scholar
• DonaldsonVHEvansRRA biochemical abnormality in hereditary angioneurotic edema: absence of serum inhibitor of C’ 1-esteraseAm J Med196335374414046003
   PubMed Web of Science ®Google Scholar
• HAEdb, C1 inhibitor gene mutation database Home page on the Internet. [Updated 2008 July 18]. Available at: http://hae.enzim.hu.
   Google Scholar
• AgostoniACicardiMHereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patientsMedicine (Baltimore)19927142062151518394
   PubMed Web of Science ®Google Scholar
• DavisAE3rdHereditary angioedema: a current state-of-the-art review, III: mechanisms of hereditary angioedemaAnn Allergy Asthma Immunol20081001 Suppl 2S7S1218220146
   PubMed Web of Science ®Google Scholar
• FieldsTGhebrehiwetBKaplanAPKinin formation in hereditary angioedema plasma: evidence against kinin derivation from C2 and in support of “spontaneous” formation of bradykininJ Allergy Clin Immunol198372154606222104
   PubMed Web of Science ®Google Scholar
• NussbergerJCugnoMAmstutzCCicardiMPellacaniAAgostoniAPlasma bradykinin in angio-oedemaLancet19983519117169316979734886
   PubMed Web of Science ®Google Scholar
• KaplanAPGhebrehiwetBThe plasma bradykinin-forming pathways and its interrelationships with complementMol Immunol201047132161216920580091
   PubMed Web of Science ®Google Scholar
• BorkKWulffKHardtJWitzkeGStaubachPHereditary angioedema caused by missense mutations in the factor XII gene: clinical features, trigger factors, and therapyJ Allergy Clin Immunol2009124112913419477491
   PubMed Web of Science ®Google Scholar
• BorkKMengGStaubachPHardtJHereditary angioedema: new findings concerning symptoms, affected organs, and courseAm J Med2006119326727416490473
   PubMed Web of Science ®Google Scholar
• KempJGCraigTJVariability of prodromal signs and symptoms associated with hereditary angioedema attacks: a literature reviewAllergy Asthma Proc200930549349919843403
   PubMed Web of Science ®Google Scholar
• BorkKStaubachPEckardtAJHardtJSymptoms, course, and complications of abdominal attacks in hereditary angioedema due to C1 inhibitor deficiencyAm J Gastroenterol2006101361962716464219
   PubMed Web of Science ®Google Scholar
• FarkasHHarmatGKaposiPNUltrasonography in the diagnosis and monitoring of ascites in acute abdominal attacks of hereditary angioneurotic oedemaEur J Gastroenterol Hepatol200113101225123011711780
   PubMed Web of Science ®Google Scholar
• BorkKResselNSudden upper airway obstruction in patients with hereditary angioedemaTransfus Apher Sci200329323523814572815
   PubMed Web of Science ®Google Scholar
• FarkasHManagement of upper airway edema caused by hereditary angioedemaAllergy Asthma Clin Immunol2010611920667122
   PubMedGoogle Scholar
• BowenTCicardiMFarkasHInternational consensus algorithm for the diagnosis, therapy and management of hereditary angioedemaAllergy Asthma Clin Immunol2010612420667127
   PubMedGoogle Scholar
• GompelsMMLockRJAbinunMC1 inhibitor deficiency: consensus documentClin Exp Immunol2005139337939415730382
   PubMed Web of Science ®Google Scholar
• LonghurstHJFarkasHCraigTHAE international home therapy consensus documentAllergy Asthma Clin Immunol2010612220667125
   PubMedGoogle Scholar
• CraigTRiedlMDykewiczMSWhen is prophylaxis for hereditary angioedema necessary?Ann Allergy Asthma Immunol2009102536637219492656
   PubMed Web of Science ®Google Scholar
• FrankMMUpdate on preventive therapy (prophylaxis) of hereditary angioedemaAllergy Asthma Proc2011321172121262094
   PubMed Web of Science ®Google Scholar
• ZurawBLHereditary angiodema: a current state-of-the-art review, IV: short- and long-term treatment of hereditary angioedema: out with the old and in with the new?Ann Allergy Asthma Immunol20081001 Suppl 2S13S1818220147
   PubMed Web of Science ®Google Scholar
• SzeplakiGVargaLValentinSAdverse effects of danazol prophylaxis on the lipid profiles of patients with hereditary angioedemaJ Allergy Clin Immunol2005115486486915806011
   PubMed Web of Science ®Google Scholar
• BorkKBygumAHardtJBenefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patientsAnn Allergy Asthma Immunol2008100215316118320917
   PubMed Web of Science ®Google Scholar
• FarkasHCzallerICsukaDThe effect of long-term danazol prophylaxis on liver function in hereditary angioedema-a longitudinal studyEur J Clin Pharmacol201066441942620024535
   PubMed Web of Science ®Google Scholar
• BorkKWitzkeGLong-term prophylaxis with C1-inhibitor (C1 INH) concentrate in patients with recurrent angioedema caused by hereditary and acquired C1-inhibitor deficiencyJ Allergy Clin Immunol19898336776822926086
   PubMed Web of Science ®Google Scholar
• KreuzWMartinez-SaguerIAygoren-PursunERusickeEHellerCKlingebielTC1-inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxisTransfusion20094991987199519497056
   PubMed Web of Science ®Google Scholar
• ZurawBLBussePJWhiteMNanofiltered C1 inhibitor concentrate for treatment of hereditary angioedemaN Engl J Med2010363651352220818886
   PubMed Web of Science ®Google Scholar
• SzemaAMPazGMerriamLStellaccioFJenJModern preoperative and intraoperative management of hereditary angioedemaAllergy Asthma Proc200930333834219368763
   PubMed Web of Science ®Google Scholar
• ZurawBLHAE therapies: past present and futureAllergy Asthma Clin Immunol2010612320667126
   PubMedGoogle Scholar
• FarkasHJakabLTemesszentandrasiGHereditary angioedema: a decade of human C1-inhibitor concentrate therapyJ Allergy Clin Immunol2007120494194717761272
   PubMed Web of Science ®Google Scholar
• CSL Behring Global Home page on the Internet. [Updated 2011]. Available at: http://www.cslbehring.com/PRelease/Berinert-Approved.htm.
   Google Scholar
• CraigTJLevyRJWassermanRLEfficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacksJ Allergy Clin Immunol2009124480180819767078
   PubMed Web of Science ®Google Scholar
• CraigTJWassermanRLLevyRJProspective study of rapid relief provided by C1 esterase inhibitor in emergency treatment of acute laryngeal attacks in hereditary angioedemaJ Clin Immunol201030682382920635155
   PubMed Web of Science ®Google Scholar
• VargaLFarkasHrhC1INH: a new drug for the treatment of attacks in hereditary angioedema caused by C1-inhibitor deficiencyExpert Rev Clin Immunol20117214315321426252
   PubMed Web of Science ®Google Scholar
• ZurawBCicardiMLevyRJRecombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedemaJ Allergy Clin Immunol20101264821827 e81420920772
   PubMed Web of Science ®Google Scholar
• CicardiMBanerjiABrachoFIcatibant, a new bradykinin-receptor antagonist, in hereditary angioedemaN Engl J Med2010363653254120818888
   PubMed Web of Science ®Google Scholar
• WilliamsABairdLGDX-88 and HAE: a developmental perspectiveTransfus Apher Sci200329325525814572818
   PubMed Web of Science ®Google Scholar
• LevyJHO’DonnellPSThe therapeutic potential of a kallikrein inhibitor for treating hereditary angioedemaExpert Opin Investig Drugs200615910771090
   PubMed Web of Science ®Google Scholar
• SchneiderLLumryWVeghAWilliamsAHSchmalbachTCritical role of kallikrein in hereditary angioedema pathogenesis: a clinical trial of ecallantide, a novel kallikrein inhibitorJ Allergy Clin Immunol2007120241642217559913
   PubMed Web of Science ®Google Scholar
• LehmannAEcallantide (Dyax/Genzyme)Curr Opin Investig Drugs200673282290
   PubMedGoogle Scholar
• BernsteinJAQaziMEcallantide: its pharmacology, pharmacokinetics, clinical efficacy and tolerabilityExpert Rev Clin Immunol201061293920383888
   PubMed Web of Science ®Google Scholar
• PremattaMGibbsJGPrattELStoughtonTRCraigTJFresh frozen plasma for the treatment of hereditary angioedemaAnn Allergy Asthma Immunol200798438338817458436
   PubMed Web of Science ®Google Scholar
• Advisory Committee Briefing Document, Kalbitor® (ecallantide) For Acute Attacks of Hereditary Angioedema (BLA 125277)0212009 Available at: http://www.fda.gov/downloads/advisorycommit-tees/committeesmeetingmaterials/drugs/pulmonary-allergydrugsadvi-sorycommittee/ucm170334.pdf.
   Google Scholar
• DX-88 (ecallantide) 1.4.1. Draft Label- KALBITOR®27112009 Available at: http://mms.businesswire.com/bwapps/mediaserver/ViewMedia?mgid=206775&vid=1.
   Google Scholar
• CicardiMLevyRJMcNeilDLEcallantide for the treatment of acute attacks in hereditary angioedemaN Engl J Med2010363652353120818887
   PubMed Web of Science ®Google Scholar
• LevyRJLumryWRMcNeilDLEDEMA4: a phase 3, double-blind study of subcutaneous ecallantide treatment for acute attacks of hereditary angioedemaAnn Allergy Asthma Immunol2010104652352920568386
   PubMed Web of Science ®Google Scholar
• Garnock-JonesKPEcallantide: in acute hereditary angioedemaDrugs201070111423143120614949
   PubMed Web of Science ®Google Scholar
• RiedlMCampionMHornPTPullmanWEResponse time for ecallantide treatment of acute hereditary angioedema attacksAnn Allergy Asthma Immunol20101056430436 e221130380
   PubMed Web of Science ®Google Scholar
• WilsonDABorkKSheaEPRentzAMBlausteinMBPullmanWEEconomic costs associated with acute attacks and long-term management of hereditary angioedemaAnn Allergy Asthma Immunol2010104431432020408341
   PubMed Web of Science ®Google Scholar
• StolzLEHornPTEcallantide: a plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedemaDrugs Today (Barc)201046854755520830315
   PubMed Web of Science ®Google Scholar